Update on rifampin drug interactions, III
- PMID: 9385296
Update on rifampin drug interactions, III
Abstract
Rifampin is a potent inducer of cytochrome P-450 oxidative enzymes. Examples of well-documented, clinically significant interactions include warfarin, oral contraceptives, cyclosporine, glucocorticoids, ketoconazole, theophylline, quinidine, digitoxin, and verapamil. Recent reports have demonstrated clinically relevant interactions with protease inhibitors, zidovudine, delavirdine, itraconazole, nifedipine, midazolam or triazolam, nortriptyline, and doxycycline. To avoid reduced therapeutic response, therapeutic failure, or toxic reactions when rifampin is added to or discontinued from medication regimens, clinicians need to be cognizant of these interactions. Enhanced knowledge of known interactions will continue to develop, including research on induction of specific cytochrome P-450 isoenzymes. New rifampin interactions will be discovered with further investigations.
Similar articles
-
Rifampin and rifabutin drug interactions: an update.Arch Intern Med. 2002 May 13;162(9):985-92. doi: 10.1001/archinte.162.9.985. Arch Intern Med. 2002. PMID: 11996607 Review.
-
Update on rifampin, rifabutin, and rifapentine drug interactions.Curr Med Res Opin. 2013 Jan;29(1):1-12. doi: 10.1185/03007995.2012.747952. Epub 2012 Nov 30. Curr Med Res Opin. 2013. PMID: 23136913 Review.
-
Update on rifampin drug interactions. II.Arch Intern Med. 1992 Apr;152(4):711-6. Arch Intern Med. 1992. PMID: 1558427 Review.
-
Update on rifampin and rifabutin drug interactions.Am J Med Sci. 2008 Feb;335(2):126-36. doi: 10.1097/MAJ.0b013e31814a586a. Am J Med Sci. 2008. PMID: 18277121 Review.
-
Update on rifampin drug interactions.Arch Intern Med. 1987 Mar;147(3):565-8. Arch Intern Med. 1987. PMID: 2881523
Cited by
-
[Cytochrom-P450 mediated drug interactions caused by antibiotics].Wien Med Wochenschr. 2006 Sep;156(17-18):508-14. doi: 10.1007/s10354-006-0336-z. Wien Med Wochenschr. 2006. PMID: 17041808 Review. German.
-
Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor.Ann Clin Microbiol Antimicrob. 2006 Feb 15;5:3. doi: 10.1186/1476-0711-5-3. Ann Clin Microbiol Antimicrob. 2006. PMID: 16480505 Free PMC article. Review.
-
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.Clin Pharmacokinet. 2001;40(11):833-68. doi: 10.2165/00003088-200140110-00004. Clin Pharmacokinet. 2001. PMID: 11735605 Review.
-
Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.Clin Pharmacokinet. 2001;40(5):327-41. doi: 10.2165/00003088-200140050-00002. Clin Pharmacokinet. 2001. PMID: 11432536 Review.
-
Pharmacokinetic Interaction between amprenavir and rifabutin or rifampin in healthy males.Antimicrob Agents Chemother. 2001 Feb;45(2):502-8. doi: 10.1128/AAC.45.2.502-508.2001. Antimicrob Agents Chemother. 2001. PMID: 11158747 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources